We use cookies to give you the best experience possible with our website and to improve our communication with you. We consider your selection and will only use the data you have approved us to gather.

These cookies help making a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.

These cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously. With this information we can constantly improve the experience we offer on our website.

These cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.

Scientific Evidence

Meeting international scientific standards is a core principle of Geistlich Biomaterials. Geistlich Bio-Oss® and Geistlich Bio-Gide® bone regeneration materials are the most researched products in regenerative dentistry worldwide1,2.

All products, such as Geistlich Mucograft® or Geistlich Mucograft® Seal, are investigated rigorously before being released on the market. Geistlich products have been tested and developed for use in various therapeutic areas, in collaboration with more than 100 universities and leading surgeons.

Bone regeneration

    • More than 900 publications validate the efficacy of Geistlich Bio-Oss® and Geistlich Bio-Gide®3.
    • Geistlich biomaterials have been used in more than 6 million patients.

    Soft-tissue regeneration

      • Development and testing of Geistlich Mucograft® and Geistlich Mucograft® Seal involved more than 150 surgeons from 13 countries.
      • Product efficacy has been documented in more than 300 long-term cases4 and more than 15 independent scientific publications.


      Biomaterials from Geistlich Pharma are the most-documented products in regenerative dentistry worldwide.


        1. iData Research Inc., US Dental Bone Graft Substitutes and other Biomaterials Market, 2011.
        2. iData Inc., European Dental Bone Graft Substitutes and other Biomaterials Market, 2012.
        3. Pubmed search (19 september 2013)
        4. 6-month or longer follow-up. data on file, Geistlich Pharma AG, Wolhusen, Switzerland.